Moreover, whether Akt plays a role in regulating the effectiveness of PRIMA-1 in sensitizing chemoresistant mutant-p53 ovarian cancer cells to CDDP, remains to be determined. This evidence concerns the gene TP53 and ovarian carcinoma.